Am. J. Respir. Crit. Care Med., Volume 164, Number 10, November 2001, S71-S75

Role of Latent Viral Infections in Chronic Obstructive Pulmonary Disease and Asthma

JAMES C. HOGG

University of British Columbia McDonald Research Laboratory/iCAPTURE Centre, St. Paul's Hospital, Vancouver, British Columbia, Canada

Acute viral respiratory tract infections are well known to precipitate asthma attacks and acute exacerbations of chronic obstructive pulmonary disease, but their role in the pathogenesis of chronic disease is poorly defined. Double-stranded DNA viruses have the ability to persist in airway epithelial cells long after the acute infection has cleared. During these latent infections, viral genes are expressed at the protein level without replication of a complete virus. The expression of the adenoviral trans-activating protein has been demonstrated in the airway epithelium of both human and animal lungs and is associated with an amplification of the cigarette smoke-induced inflammatory response. Studies of cultured human airway epithelial cells have also shown that transfection with this viral gene upregulates the expression of intercellular adhesion molecule 1 and interleukin 8 by these cells when they are challenged with endotoxin. In guinea pigs, cigarette smoke-induced emphysema is amplified by latent adenoviral infection. Furthermore, this infection independently increased the number of CD-8 cells, whereas the cigarette smoke independently increased the number of CD-4 cells in the inflammatory infiltrate. On the other hand, allergen-induced lung inflammation was uninfluenced by latent adenoviral infection in the guinea pig, but the latent infection caused the eosinophilic component of this response to become steroid resistant. These studies suggest that latent adenoviral infections may have a role in the pathogenesis of obstructive airway disease by amplifying the response to cigarette smoke and inducing steroid resistance.

This article has been cited by other articles:

				S. G. Kelsen, M. O. Aksoy, M. Georgy, R. Hershman, R. Ji, X. Li, M. Hurford, C. Solomides, W. Chatila, and V. Kim Lymphoid Follicle Cells in Chronic Obstructive Pulmonary Disease Overexpress the Chemokine Receptor CXCR3 Am. J. Respir. Crit. Care Med., May 1, 2009; 179(9): 799 - 805. [Abstract] [Full Text] [PDF]

				T. Jartti, W-M. Lee, T. Pappas, M. Evans, R. F. Lemanske Jr, and J. E. Gern Serial viral infections in infants with recurrent respiratory illnesses Eur. Respir. J., August 1, 2008; 32(2): 314 - 320. [Abstract] [Full Text] [PDF]

				J. Goulding, R. Snelgrove, J. Saldana, A. Didierlaurent, M. Cavanagh, E. Gwyer, J. Wales, E. L. Wissinger, and T. Hussell Respiratory Infections: Do We Ever Recover? Proceedings of the ATS, December 1, 2007; 4(8): 618 - 625. [Abstract] [Full Text] [PDF]

				A. Koch, M. Gaczkowski, G. Sturton, P. Staib, T. Schinkothe, E. Klein, A. Rubbert, K. Bacon, K. Wassermann, and E. Erdmann Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking Eur. Respir. J., January 1, 2007; 29(1): 42 - 50. [Abstract] [Full Text] [PDF]

				K. Crothers, A. A. Butt, C. L. Gibert, M. C. Rodriguez-Barradas, S. Crystal, A. C. Justice, and for the Veterans Aging Cohort 5 Project Team Increased COPD Among HIV-Positive Compared to HIV-Negative Veterans. Chest, November 1, 2006; 130(5): 1326 - 1333. [Abstract] [Full Text] [PDF]

				A Bush Coughs and wheezes spread diseases: but what about the environment? Thorax, May 1, 2006; 61(5): 367 - 369. [Full Text] [PDF]

				A. Roghanian, S. E. Williams, T. A. Sheldrake, T. I. Brown, K. Oberheim, Z. Xing, S. E. M. Howie, and J.-M. Sallenave The Antimicrobial/Elastase Inhibitor Elafin Regulates Lung Dendritic Cells and Adaptive Immunity Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 634 - 642. [Abstract] [Full Text] [PDF]

				A. R. Falsey, M. A. Formica, P. A. Hennessey, M. M. Criddle, W. M. Sullender, and E. E. Walsh Detection of Respiratory Syncytial Virus in Adults with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 639 - 643. [Abstract] [Full Text] [PDF]

				C. E. Girod and T. E. King Jr. COPD: A Dust-Induced Disease? Chest, October 1, 2005; 128(4): 3055 - 3064. [Abstract] [Full Text] [PDF]

				P. J. Barnes, I. M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J., March 1, 2005; 25(3): 552 - 563. [Abstract] [Full Text] [PDF]

				L. D. Snyder and M. D. Eisner Obstructive Lung Disease Among the Urban Homeless Chest, May 1, 2004; 125(5): 1719 - 1725. [Abstract] [Full Text] [PDF]

				P.J. Barnes, S.D. Shapiro, and R.A. Pauwels Chronic obstructive pulmonary disease: molecular and cellularmechanisms Eur. Respir. J., October 1, 2003; 22(4): 672 - 688. [Abstract] [Full Text] [PDF]

				T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF]